South Sudan vs Syrian Arab Republic: Immunization, Hib3
South Sudan
73.0%
in 2024
Syrian Arab Republic
73.0%
in 2024
South Sudan rank
157th
Syrian Arab Republic rank
157th
Immunization, Hib3 over time
- South Sudan
- Syrian Arab Republic
How they compare
South Sudan currently reports 73.0% against 73.0% in Syrian Arab Republic, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Syrian Arab Republic ahead.
South Sudan ranks 157th and Syrian Arab Republic ranks 157th of 191 countries.
Across the 2 decades both report, South Sudan averaged higher in 1 and Syrian Arab Republic in 1.
Head to head by decade
| Decade | South Sudan | Syrian Arab Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 52.6% | 59.4% | 6.8% | Syrian Arab Republic |
| 2020s | 71.0% | 64.2% | 6.8% | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, South Sudan or Syrian Arab Republic?
- South Sudan, at 73.0% against 73.0% in Syrian Arab Republic as of 2024.
- What is the difference in immunization, hib3 between South Sudan and Syrian Arab Republic?
- 0.0%, with South Sudan ahead.
- How many years of comparable data are there for South Sudan and Syrian Arab Republic?
- 10 years are reported by both, from 2015 to 2024.
- How do South Sudan and Syrian Arab Republic rank globally for immunization, hib3?
- South Sudan ranks 157th and Syrian Arab Republic ranks 157th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.